As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: May 16, 2012
by Gregg Zoroya for USA Today:
A generation of Iraq and Afghanistan veterans exposed to explosions may be at risk for early-onset dementia, according to a new study that looked at the autopsied brains of four former combat service members and four athletes.
Scientists said their work showed evidence of a progressive degenerative brain disorder known as chronic traumatic encephalopathy (CTE), a disease found in recent years among deceased professional football players who had suffered multiple concussions.
What researchers said was particularly alarming was evidence that the disorder could result from exposure to a single blast and that several hundred thousand U.S. troops may have suffered concussions in Iraq and Afghanistan, most of them from exposure to blasts.
“Ramifications are that these hundreds of thousands of military personnel are at risk for this disorder. It doesn’t mean by any means that they all have or will get it. But they are at risk for it,” says Ann McKee, a Department of Veterans Affairs scientist and co-author of the study inScience Translational Medicine.
The study findings were based on comparing brain autopsies of four Iraq and Afghanistan veterans with four young athletes, as well as studying mice exposed to a simulated blast.
Army and Navy brain-trauma scientists who treat or study soldiers and Marines who suffer combat brain injuries applauded the study for focusing attention on CTE, but questioned some of the conclusions.
Given the limited number of brain autopsies performed in the study, Army Col. Geoffrey Ling cautioned against sweeping conclusions about risks to veterans in the future. Navy Cmdr. Jack Tsao noted that most of the deceased veterans had also suffered concussions from blows to the head, calling into question whether blast exposure was the true cause of long-term damage.
Daniel Perl, professor of pathology and a neuropathologist at the Uniformed Services University of the Health Sciences, says the findings will certainly spur more research. “It’s not the whole story. It’s just the beginning, and it raises a whole number of additional questions that will need to be answered. But it is important,” says Perl, who is creating a lab to study the brains of deceased troops who suffered combat concussions.
Progression of CTE — marked by memory loss, suicidal thoughts and aggression — is slow, but appears irreversible after eight to 10 years, with the prospect of early dementia within a few decades, the scientists said.
“We need to find some answers quickly so that we can treat veterans, military personnel, before anything gets worse,” says Lee Goldstein, a scientist with Boston University and lead author.
The four veterans whose brains were autopsied served in Iraq or Afghanistan. Their average age was 32. All showed signs of CTE, the study says.
Two died of burst blood vessels in the brain, one from a pain medication overdose and the fourth from suspected suicide. Three had mild traumatic brain injuries from roadside bomb blasts, and one had several concussions, but none caused by a blast.
To support their autopsy findings, researchers studied the effects of a single blast on the brains of mice. The study of mice exposed to a simulated blast led McKee and Goldstein to conclude that supersonic blast waves caused by expanding gas from a detonation can lead to brain injury.
A “blast wind” of 330 mph whips the brain about violently, damaging cells and blood vessels and triggering a cascade of events that lead to a destructive buildup of a tau protein in the brain — evidence of CTE. “You may be getting in one blast exposure the equivalent of multiple hits on the playing field,” Goldstein says.
Thirty-six million people worldwide suffer from Alzheimer’s disease and dementia. In Canada, 25,000 new cases are diagnosed each year. Those sobering numbers have researchers around the globe racing to come up with new ways to...
he Food and Drug Administration issued new guides on drug development for neurological disorders. This sets the stage for possible treatments for Alzheimer’s. The disease-oriented development guide documents will provide details on how researchers...
For young adults with autosomal dominant Alzheimer’s disease (AD), molecular markers can identify changes associated with the disease before clinical onset, according to a study published online Feb. 12 in JAMA Neurology. Yakeel T. Quiroz, Ph.D., from Massachusetts...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.